US Patent 8541436 Morphinan compounds
Patent 8541436 was granted and assigned to Concert Pharmaceuticals on September, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08541436 Morphinan compounds US Patent 8541436 Morphinan compounds
Infobox
Patent Number
085414360
Patent Number
85414360
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
085414360
Date of Patent
September 24, 2013
0Patent Application Number
131189350
Date Filed
May 31, 2011
0Patent Primary Examiner
Edits on 18 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08541436 Morphinan compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08541436
Date of patent
September 24, 2013
Patent application number
13118935
Date Filed
May 31, 2011
Patent primary examiner
Find more entities like US Patent 8541436 Morphinan compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
